Post-Transplant, Parvovirus B19 DNA, Quantitative, Real-Time PCR, Plasma : 18068

PTPVPP or 18068

PTxplnt, Specialized, Txplnt, Services, Quest Advanced

1 mL (0.5 mL minimum) plasma collected in an EDTA (lavender-top) tube.

Refrigerated

Room temperature: 48 hours; Refrigerated: 7 days; Frozen: Unacceptable

Received frozen

Sunday - Saturday

1 day

Laboratory test results should always be considered in the context of clinical observations. This test was developed, and its performance characteristics determined by med fusion. It has not been cleared or approved by the U.S. Food and Drug Administration (FDA). The FDA has determined that such clearance or approval is not necessary. This test is used for clinical purposes. It should not be regarded as investigational for research. This laboratory is certified under the Clinical Laboratory Improvement Amendments of 1988 (CLIA) as qualified to perform high complexity clinical laboratory testing.

Not Detected

Parvovirus B19 infection has a wide variety of disease manifestations, including Fifth disease, transient aplastic crisis, persistent anemia and congenital hydrops fetalis. Quantification of parvovirus B19 genomic DNA is based upon Real-Time PCR amplification and detection. Reportable range is 100 to 100,000,000 copies/mL (2.00 to 8.00 Log copies/mL).